When choosing among them, factors such as glycemic efficacy, weight effects and patient preferences may take precedence over concerns about major differences in [GI] risk. She added clinicians should continue to monitor for GI symptoms, particularly early in treatment, as these events, while uncommon, remain more frequent than with some other diabetes drug classes. According to Alkabbani and colleagues, recent trials revealed that dulaglutide (Trulicity, Eli Lilly), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly) increased the risk for mild to serious GI adverse events like pancreatitis, constipation, nausea, vomiting and biliary disease
These medicines are human GLP-1 analoguesmodified versions of the hormone that naturally occurs in our own bodieswith strategic alterations to prevent rapid breakdown and extend their therapeutic effect
Vitamin D Injections Boost Your Body's Natural Defenses Vitamin D, often referred to as the sunshine vitamin, is crucial for maintaining optimal health, particularly for bone health, immune function, and overall vitality
He has been involved in clinical research for more than a decade
Monthly drugs are for patients who do not
On Ozempic & the GLP-1 Boom ft
